These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 32106219

  • 1. Targeting tRNA-synthetase interactions towards novel therapeutic discovery against eukaryotic pathogens.
    Kelly P, Hadi-Nezhad F, Liu DY, Lawrence TJ, Linington RG, Ibba M, Ardell DH.
    PLoS Negl Trop Dis; 2020 Feb; 14(2):e0007983. PubMed ID: 32106219
    [Abstract] [Full Text] [Related]

  • 2. Genetic manipulation of Leishmania donovani threonyl tRNA synthetase facilitates its exploration as a potential therapeutic target.
    Chadha S, Vijayan R, Gupta S, Munde M, Gourinath S, Madhubala R.
    PLoS Negl Trop Dis; 2018 Jun; 12(6):e0006575. PubMed ID: 29897900
    [Abstract] [Full Text] [Related]

  • 3. Thiol redox biology of trypanosomatids and potential targets for chemotherapy.
    Leroux AE, Krauth-Siegel RL.
    Mol Biochem Parasitol; 2016 Jun; 206(1-2):67-74. PubMed ID: 26592324
    [Abstract] [Full Text] [Related]

  • 4. Genetic validation of aminoacyl-tRNA synthetases as drug targets in Trypanosoma brucei.
    Kalidas S, Cestari I, Monnerat S, Li Q, Regmi S, Hasle N, Labaied M, Parsons M, Stuart K, Phillips MA.
    Eukaryot Cell; 2014 Apr; 13(4):504-16. PubMed ID: 24562907
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Structure-guided optimization and mechanistic study of a class of quinazolinone-threonine hybrids as antibacterial ThrRS inhibitors.
    Guo J, Chen B, Yu Y, Cheng B, Ju Y, Tang J, Cai Z, Gu Q, Xu J, Zhou H.
    Eur J Med Chem; 2020 Dec 01; 207():112848. PubMed ID: 32980741
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Recent Advancement in the Search of Innovative Antiprotozoal Agents Targeting Trypanothione Metabolism.
    Saccoliti F, Di Santo R, Costi R.
    ChemMedChem; 2020 Dec 15; 15(24):2420-2435. PubMed ID: 32805075
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Computational and Investigative Study of Flavonoids Active Against Typanosoma cruzi and Leishmania spp.
    Ribeiro FF, Junior FJ, da Silva MS, Scotti MT, Scotti L.
    Nat Prod Commun; 2015 Jun 15; 10(6):917-20. PubMed ID: 26197515
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Inhibitors of the Purine Salvage Pathway: A Valuable Approach for Antiprotozoal Chemotherapy?
    Berg M, Van der Veken P, Goeminne A, Haemers A, Augustyns K.
    Curr Med Chem; 2010 Jun 15; 17(23):2456-81. PubMed ID: 20491648
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Typical 2-Cys peroxiredoxins in human parasites: Several physiological roles for a potential chemotherapy target.
    Angelucci F, Miele AE, Ardini M, Boumis G, Saccoccia F, Bellelli A.
    Mol Biochem Parasitol; 2016 Jun 15; 206(1-2):2-12. PubMed ID: 27002228
    [Abstract] [Full Text] [Related]

  • 20. Mechanistic insights into mode of actions of novel oligopeptidase B inhibitors for combating leishmaniasis.
    Goyal S, Grover S, Dhanjal JK, Goyal M, Tyagi C, Chacko S, Grover A.
    J Mol Model; 2014 Mar 15; 20(3):2099. PubMed ID: 24567150
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.